The title compound, C 13 H 15 N 3 O 7 , crystallizes as two independent molecules which differ in their conformation. Intermolecular hydrogen bonding between the amide and carboxylic acid groups as NÐHÁ Á ÁO C interactions results in the formation of one-dimensional chains with NÁ Á ÁO distances of 2.967 (6) and 3.019 (6) A Ê . Neighbouring chains are linked by C OÁ Á ÁHÐO interactions to form a twodimensional network, with OÁ Á ÁO distances of 2.675 (6) and 2.778 (6) A Ê .
Comment
The study of biologically important molecules continues to be of primary importance in medicinal chemistry. Processes such as blood coagulation, hormone processing, viral replication and cancer-cell invasion are critically dependent on protease enzymes which are attractive target molecules in the design of speci®c and selective drugs. Important protease inhibitors are usually based on modi®ed amino acids incorporating structural features which determine normal enzyme-substrate recognition processes. Structure-based drug design strategies to identify interactions between a potential inhibitor and target receptor require accurate inhibitor structures. We are currently studying structure±activity relationships and molecular-recognition processes in biologically important molecules such as the title compound N-3,5-dinitrobenzoyl-lleucine, (I), for applications in drug design (Gallagher & Murphy, 1999; Gallagher et al., , 2000 .
In (I), two independent molecules are present which differ in conformation in space group P1 (No. 1). The bond lengths are largely in accord with anticipated values (Orpen et al., 1994) . The molecules differ in conformation about the N1ÐC2 bond, with N1ÐC2ÐC4 angles of 115.9 (5) and 110.1 (5)
, and C1ÐN1ÐC2ÐC3 torsion angles of À56.1 (7) and 81.5 (7) in A and B, respectively. The aromatic C1ÐC11ÐC12 and C1Ð C11ÐC16 angles are 123.1 (6)/116.7 (6) in molecule A and 125.6 (5)/116.6 (5) in molecule B. This results from the intramolecular contacts H16AÁ Á ÁO5A 2.45 A Ê and H1AÁ Á ÁH12A 2.08 A Ê in A, and H16BÁ Á ÁO5B 2.42 A Ê and H1BÁ Á ÁH12B 2.14 A Ê in B (O5BÁ Á ÁH2B 2.48 A Ê ). The aromatic ring planes are oriented at angles of 19.1 (4) (A) and 12.8 (6) (B) to their respective amide groups (O5/C1/N1/C2) and the nitro groups are almost coplanar (<10 from the aromatic ring planes), with O4A deviating by 0.265 (11) A Ê from the C 6 ring plane. The carboxylate (C2/C3/O6/O7) groups are almost normal to the (C11/C1/O5/N1/C2) planes, with angles of 85.9 (2) and 79.1 (2) in molecules A and B, respectively. The molecules are aligned in one-dimensional chains as Spek, 1998) showed that there were no solventaccessible voids.
The structure of l-leucine has been reported previously (Harding & Howieson, 1976; Collect et al., 1986; Go È rbitz & Dalhus, 1996) and contains two crystallographically independent zwitterions having similar conformations in the asymmetric unit, unlike (I) above, where the two molecules differ signi®cantly in conformation.
Experimental N-3,5-Dinitrobenzoyl-l-leucine was synthesized by the reaction of 3,5-dinitrobenzoyl chloride with the parent l-leucine. Recrystallization from ethanol/water afforded colourless plate-like crystals suitable for X-ray analysis [m.p. 451±453 K (uncorrected); literature 187 (Vogel, 1989) Crystal data Molecule (I) crystallized in the triclinic system, space group P1 or P1. The molecule is chiral and space group P1 was chosen and con®rmed by the analysis. The absolute con®guration is based on lleucine. The crystal diffracted quite weakly but suf®cient data (hemisphere) were collected to establish the structure and elucidate the hydrogen bonding interactions. The absolute structure is not reliably determined by this X-ray analysis, but is inferred from the known absolute con®guration of the l-leucine used in the synthesis.
Data collection: CAD-4-PC Software (Enraf±Nonius, 1992); cell re®nement: SET4 and CELDIM (Enraf±Nonius, 1992) ; data reduction: DATRD2 in NRCVAX96 (Gabe et al., 1989 ); program(s) used to solve structure: SHELXS97 (Sheldrick, 1997); program(s) used to re®ne structure: NRCVAX96 and SHELXL97 (Sheldrick, 1997) ; software used to prepare material for publication: NRCVAX96, SHELXL97 and PREP8 (Ferguson, 1998) .
